» Authors » Thierry H Lejemtel

Thierry H Lejemtel

Explore the profile of Thierry H Lejemtel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 1599
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Colombo P, Castagna F, Onat D, Wong K, Harxhi A, Hayashi Y, et al.
J Card Fail . 2023 Aug; 30(4):580-591. PMID: 37625581
Background: Venous congestion (VC) is a hallmark of symptomatic heart failure (HF) requiring hospitalization; however, its role in the pathogenesis of HF progression remains unclear. We investigated whether peripheral VC...
2.
Ennezat P, Guerbaai R, Lejemtel T, Hansen M
Hosp Pract (1995) . 2022 Mar; 50(2):89-92. PMID: 35236204
No abstract available.
3.
Chaanine A, Lejemtel T, Delafontaine P
J Clin Med . 2020 Nov; 9(11). PMID: 33172082
The mitochondria are mostly abundant in the heart, a beating organ of high- energy demands. Their function extends beyond being a power plant of the cell including redox balance, ion...
4.
Mancini D, Lejemtel T
J Card Fail . 2019 Oct; 25(12):969-970. PMID: 31629788
No abstract available.
5.
Lin J, Chudasama N, Hayashi Y, Hawk C, Ramnauth S, Wong K, et al.
Physiol Rep . 2017 Mar; 5(6). PMID: 28320895
Endothelin-1 (ET-1) is a pivotal mediator of vasoconstriction and inflammation in congestive states such as heart failure (HF) and chronic kidney disease (CKD). Whether peripheral venous congestion (VC) increases plasma...
6.
Colombo P, Onat D, Harxhi A, Demmer R, Hayashi Y, Jelic S, et al.
Eur Heart J . 2013 Nov; 35(7):448-54. PMID: 24265434
Aims: Volume overload and venous congestion are typically viewed as a consequence of advanced and of acute heart failure (HF) and renal failure (RF) although it is possible that hypervolaemia...
7.
Ennezat P, Vannesson C, Bouabdallaoui N, Marechaux S, Asseman P, Lejemtel T
Expert Opin Pharmacother . 2011 Feb; 12(6):883-97. PMID: 21348772
Introduction: Angiotensin-converting enzyme (ACE) inhibition is clearly beneficial in patients with hypertension, heart failure, and post-myocardial infarction left ventricular (LV) dysfunction. However, whereas initial trials had reported a benefit of...
8.
Jeger R, Urban P, Harkness S, Tseng C, Stauffer J, Lejemtel T, et al.
Acute Card Care . 2011 Jan; 13(1):14-20. PMID: 21244231
Background: A pooled analysis in cardiogenic shock due to acute coronary syndromes is desirable to assess the effect of early revascularization (ERV) across all ages and a wide spectrum of...
9.
Marechaux S, Six-Carpentier M, Bouabdallaoui N, Montaigne D, Bauchart J, Mouquet F, et al.
Heart Vessels . 2010 Nov; 26(3):313-20. PMID: 21063875
The relative impact of comorbidities and parameters of left ventricular diastolic function on clinical outcome has not been thoroughly investigated in patients who are hospitalized for heart failure decompensation and...
10.
Marechaux S, Carpentier E, Six-Carpentier M, Asseman P, Lejemtel T, Jude B, et al.
Arch Cardiovasc Dis . 2010 Jul; 103(4):227-35. PMID: 20656633
Background: Left ventricular (LV) longitudinal deformation is a good marker of intrinsic myocardial dysfunction in pressure overload cardiomyopathies. Aim: To assess the effect of valvuloarterial haemodynamic load on LV longitudinal...